Novartis bags approval of Xolair
Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark receives $4 million through Swiss subsidiary
Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…
Medigene signs licence agreement with Falk Pharma
Falk Pharma will initially concentrate on development in primary biliary cirrhosis (PBC)
PHARMA Pro & Pack Expo 2014 to be held in Mumbai
Around 20,000 pharma trade professional/decision makers are likely to attend the event
Industry, regulators in frank discussion at 5th India Pharma Summit
DoP, WHO and FICCI event focused strengthening infrastruture, clarifying regulations pertaining to APIs, drug trials, R&D
HIV Congress 2014 deliberates upon strategies for fighting HIV epidemic
700 participants took part in the event
Daiichi Sankyo India, Ranbaxy & Royal Society Chemistry organise symposium
Declare Research Awards 2012, honour five outstanding scientists and five young science scholars
Social media campaign to be launched for TB awareness
To provide a convenient platform for allopathic doctors to register with the RNTCP’s national notification system
Walking the talk on GCP
“If we are interested in exporting medicines, we have to also import the standards.”